About Istituto Nazionale dei Tumori
La Fondazione IRCCS Istituto Nazionale dei Tumori, è un ospedale pubblico milanese dedicato esclusivamente alla cura del cancro, sia dal punto di vista clinico che da quello della ricerca.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Istituto Nazionale dei Tumori
During the past decade, Istituto Nazionale dei Tumori conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Istituto Nazionale dei Tumori
According to Clinical.Site data, the most researched conditions in "Istituto Nazionale dei Tumori" are
"Diffuse Large B-Cell Lymphoma" (1 trials) and "Non-Squamous Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Istituto Nazionale dei Tumori" in a lesser frequency.
Clinical Trials Intervention Types at Istituto Nazionale dei Tumori
Most popular intervention types in "Istituto Nazionale dei Tumori" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab (MPDL3280A) [TECENTRIQ], an engineered anti-PDL1 antibody" (1 trials), "Carboplatin" (1 trials), "Cisplatin" (1 trials), "Cyclophosphamide" (1 trials) and "Doxorubicin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Istituto Nazionale dei Tumori
The vast majority of trials in "Istituto Nazionale dei Tumori" are
2 trials for "All" genders.
Clinical Trials Status at Istituto Nazionale dei Tumori
Currently, there are NaN active trials in "Istituto Nazionale dei Tumori".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Istituto Nazionale dei Tumori,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Istituto Nazionale dei Tumori, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".